Advertisement

Advertisement

AMRN Stock Latest News

Amarin reinstated with an Underweight at JPMorgan

The FlyAmarin reinstated with an Underweight at JPMorgan

Amarin Earnings Call: Cost Cuts, Cash Strength, Mixed Sales

PremiumCompany Announcements

Amarin Earnings Call: Cost Cuts, Cash Strength, Mixed Sales

1M ago

Is AMRN a Buy, Before Earnings?

PremiumPre-Earnings

Is AMRN a Buy, Before Earnings?

2M ago

Amarin Shareholders Reject Dilution, Governance Proposals at AGM

PremiumCompany Announcements

Amarin Shareholders Reject Dilution, Governance Proposals at AGM

4M ago

Amarin Earnings Call Signals Leaner, Global Growth

PremiumCompany Announcements

Amarin Earnings Call Signals Leaner, Global Growth

5M ago

AMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-EarningsAMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

5M ago

Amarin Streamlines Board, Updates Director Equity Compensation Plan

Company Announcements

Amarin Streamlines Board, Updates Director Equity Compensation Plan

6M ago

Amarin highlights new recommendation for treatment of CV risk

The Fly

Amarin highlights new recommendation for treatment of CV risk

6M ago

Amarin to present data in patients at extreme cardiovascular risk

PremiumThe Fly

Amarin to present data in patients at extreme cardiovascular risk

6M ago

Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk

PremiumCompany Announcements

Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk

6M ago

Amarin Earnings Call: Cost Cuts, Cash, and Crosswinds

PremiumCompany Announcements

Amarin Earnings Call: Cost Cuts, Cash, and Crosswinds

6M ago

Amarin highlights recent data published on REDUCE-IT study

PremiumThe Fly

Amarin highlights recent data published on REDUCE-IT study

6M ago

Amarin reports Q4 non-GAAP EPS 1c vs. (2c) last year

PremiumThe FlyAmarin reports Q4 non-GAAP EPS 1c vs. (2c) last year

7M ago

Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities

The Fly

Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities

7M ago

Amarin issues call to action for American Heart Month

The Fly

Amarin issues call to action for American Heart Month

7M ago

AMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

AMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

7M ago

Amarin comments on recent innovations for patients with elevated triglycerides

PremiumThe Fly

Amarin comments on recent innovations for patients with elevated triglycerides

8M ago

Amarin expects Q4 net revenue $48M-$43M

PremiumThe Fly

Amarin expects Q4 net revenue $48M-$43M

8M ago

Amarin believes it’s in ‘best position’ to capitalize on opportunities in FY26

PremiumThe Fly

Amarin believes it’s in ‘best position’ to capitalize on opportunities in FY26

8M ago

Amarin announces new post hoc analysis of aspirin use in REDUCE-IT

PremiumThe FlyAmarin announces new post hoc analysis of aspirin use in REDUCE-IT

10M ago

Amarin Corporation’s Financial Health at Risk Amid Global Trade Uncertainties

Company Announcements

Amarin Corporation’s Financial Health at Risk Amid Global Trade Uncertainties

11M ago

Amarin Corporation Reports Q3 2025 Financial Results

Company Announcements

Amarin Corporation Reports Q3 2025 Financial Results

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >